Fundraising Fox
NeuTigers
Princeton, US · Founded 2018 · Delaware corporation
Find your way into NeuTigers
Sign up to see every warm intro you have to NeuTigers
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuTigers team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuTigers develops edge-AI decision support software that remotely detects and monitors early symptoms of chronic and rare diseases, aiming to enable proactive intervention for healthcare providers. Founded in 2018, the company applies deep learning and IoT-based techniques to process real-time data at the source for healthcare and industrial applications.
Founders & leadership
NeuTigers was founded in 2018 by Adel Laoui and Niraj K. Jha.
AL
Adel LaouiCEO and FounderAdel Laoui is CEO and founder of NeuTigers, which develops edge-AI software for early detection and monitoring of chronic and rare diseases using wearable data. He previously held leadership positions in pharmaceutical R&D and life-sciences software at companies including Aventis, Sanofi, and Accelrys/BIOVIA, with over 25 years of experience in those domains.
VG
Vishu GhanakotaChief Technology OfficerVishu Ghanakota is Chief Technology Officer at NeuTigers, which develops edge-AI software for early disease detection and monitoring. He has expertise in machine learning operations, healthcare compliance, cloud infrastructure, and real-time data processing systems.
PM
Paul MoorcroftChief Financial OfficerHe holds a Master's degree in Professional Accountancy and is a UK Chartered Accountant (ACCA), with prior experience in finance and operations leadership at service-based organizations.
JR
John RavalliNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2018
▶$625KraisedJun 2020 · 10 investors · Other TechnologyRule 506(b)
▶$625KraisedJun 2020 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Karim BenjellounDirector
- John RavalliDirector
- Paul MoorcroftExecutive Officer
- Adel LaouiExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $625K
- Minimum investment
- $25K
- Proceeds to insiders
- $200K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$450KraisedNov 2018 · 1 investors · Other TechnologyRule 506(b)
▶$450KraisedNov 2018 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Adel LaouiExecutive Officer, Director, Promoter
- John RavalliDirector
- Karim BenjellounDirector
- Offering amount
- $5M
- Amount sold
- $450K
- Minimum investment
- $450K
- Proceeds to insiders
- $200K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does NeuTigers do?
- NeuTigers develops edge-AI decision support software that remotely detects and monitors early symptoms of chronic and rare diseases, aiming to enable proactive intervention for healthcare providers. Founded in 2018, the company applies deep learning and IoT-based techniques to process real-time data at the source for healthcare and industrial applications.
- Who founded NeuTigers?
- NeuTigers was founded by Adel Laoui, Niraj K. Jha in 2018.
- How much funding has NeuTigers raised?
- NeuTigers has disclosed $1.1M raised across 2 rounds.
- Where is NeuTigers headquartered?
- NeuTigers is headquartered in Princeton, US.